D-Tails Research Lab
Advanced Diagnostic Equipment
D-Tails Team

Welcome to D-Tails

Leading Innovations in Diagnostics with Cutting-edge Research

Transforming scientific research into real-world applications

Leading the way in early detection of cancer and neurodegenerative diseases

Be part of the future of medical diagnostics

Mission: support the community's needs through our commitment, passion and research

We are targeting solutions that could be easily and ​cost effectively applied.
We believe in progressing research where new horizons are revealed.
Our future lies in the unseen and the unknown.

Key Aspects

The Way We Work

Innovative solutions for early detection of cancer and neurodegenerative diseases.

Advanced Research

Harnessing years of scientific expertise to develop cutting-edge diagnostic tools.

Interdisciplinary Team

Combining knowledge from biochemistry, cell biology, physics, and engineering to create effective solutions.

State-of-the-Art Facilities

Conducting experiments in top-tier labs with the latest instrumentation and technology.

Collaborative Environment

Working closely with leading scientific communities to foster innovation and progress.

Proven Track Record

Developing patents and publishing results in peer-reviewed journals.

Commitment to Excellence

Dedicated to improving diagnostics and treatment through continuous research and development.

Our Approach

Transforming Research into Reality

Advancing Diagnostics

Utilizing cutting-edge technology and interdisciplinary expertise to make significant advancements in medical diagnostics.

Innovative Technologies

Developing new imaging techniques and diagnostic tools for early disease detection.

Collaborative Efforts

Partnering with leading institutions to enhance research capabilities and outcomes.

Community Engagement

Developing accessible diagnostic solutions that enhance quality of life and contribute to societal well-being.

Key People - BoD

Alessandro M. Cremona Image

Alessandro M. Cremona

Chairman | CEO

Alessandro graduated in Theoretical Physics (Milano), further studies in the USA, MBA (SDA Bocconi). He then developed his career in the financial sector, where he was CEO of the Italian branch of the largest Asian investment bank for twenty years. At the beginning of the last decade, he became interested in sustainability, circularity, and ESG criteria, always from an economic-financial point of view.

Currently, Alessandro is Chairman of Goldmann & Partners Srl SB, awarded B Corp as Best For the World in Environmental and Governance (July 2021). He is also Executive Chairman of D-Tails, an innovative start-up that has in place a joint lab with IIT-Università Sapienza in the fields of neurodegenerative diseases and cancer diagnostics; member of the board of CrestOptics SpA, a MedTech company (majority shareholder Apposite Capital LLP) of which he is also a member of the Remuneration, Diversity, Audit and Sustainability Committees.

Alessandro is also a member of the board of SoGeMi SpA, an in-house company of the Municipality of Milan that manages the wholesale food market of the city. He has held other board positions in real estate asset management companies, industrial corporates, and merchant banks. He has been a member of Aspen Institute Italia since 1996. In 2013 he founded a start-up (telemedicine), which later merged into another company of an American group.
Vincenzo Ricco

Vincenzo Ricco

Founder | Director | R&D proxy

Thirty-five years of experience in system design and field tests in Infrared technology and imaging systems. For the last 25 years, he has been on the BOD of several companies manufacturing or selling Electro-Optics products. He played a key role in establishing and guiding research and development projects carried on within the Joint Lab collaboration between CrestOptics and IIT (Italian Institute of Technology).

Since October 2021 he is the CEO of D-TAILS, spinoff of CrestOptics dedicated to diagnostics.
Alberto Boffi

Alberto Boffi

NED | Scientific Director

Prof. Alberto Boffi MD graduated in 1986 at Rome "Sapienza" and he is currently Full Professor of Molecular Biology, Department of Biochemistry in Rome, "Sapienza".

He is an expert in biochemistry and protein engineering, comprising molecular biology and biophysical technologies.

Since 2018 he was Principal investigator at Crest Optics in several national and international research projects in the field of Alzheimer diagnostics concerning the detection of Tau protein aggregates by fluorescence and luminescence methods, comprising the discovery and synthesis of novel fluorescent molecules, now IP of D-tails.

🌐 https://corsidilaurea.uniroma1.it/it/users/albertoboffiuniroma1it
Renato Giacobbo Scavo

Renato Giacobbo Scavo

NED | Co-Founder

A degree in Electronic Engineering at University of Rome and an MBA at HEC School of Business, he has been working for over 20 years in Venture Capital and Private Equity industries.

Manager at Bain & Company focused on innovation, Investment Director at Jupiter Finance and then since 2007 serial entrepreneur and investor with several successful exits in high-tech industries.
Federico Bellan

Federico Bellan

NED | Intellectual Property

He works in the field of intellectual property rights law, general commercial and corporate law since 2001.

He has over the years developed a specific expertise in technology transfer sector.

Holds a Master of Laws (LL.M) in Intellectual Property organized by the WIPO (World Intellectual Property Organization) Academy and the Law School of the Turin University.

Authorised to practice law (2003) Bar Association of Turin.

Explore Our Latest Research

View all posts »

Stay updated with the latest developments in our diagnostic research. Discover groundbreaking findings and learn more about the technologies shaping the future of healthcare.

FAQs

Frequently Asked Questions

Learn more about D-Tails and our innovative approaches to medical diagnostics.

What is D-Tails?

D-Tails is a pioneering company focused on developing advanced diagnostic tools for early detection of cancer and neurodegenerative diseases.

What makes D-Tails unique?

Our interdisciplinary team, cutting-edge research, and state-of-the-art facilities set us apart in the field of medical diagnostics.

How does D-Tails contribute to early disease detection?

We leverage advanced imaging techniques, biochemical markers, and data analysis to develop reliable and accurate diagnostic tools.

Who are the key people at D-Tails?

Our team includes experts in biochemistry, cell biology, physics, engineering, and data analysis, all working together to drive innovation.

How can I get involved with D-Tails?

You can join our community, collaborate with us on research projects, or participate in our events and webinars.

What are the main applications of D-Tails’ technology?

Our technology is primarily applied in early cancer detection and neurological research, enabling non-invasive diagnostics and improving patient outcomes.

10+
Patents
50+
Publications
30+
Researchers
15+
Collaborations

Join Us in
Pioneering Diagnostics

Be a part of our mission to revolutionize medical diagnostics.Contact us to learn more and get involved.